Predictive Value of NT-proBNP, FGF21, Galectin-3 and Copeptin in Advanced Heart Failure in Patients with Preserved and Mildly Reduced Ejection Fraction and Type 2 Diabetes Mellitus.

Ianos, Raluca Diana et al.·Medicina (Kaunas·2024·
RPEP-084262024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Predictive Value of NT-proBNP, FGF21, Galectin-3 and Copeptin in Advanced Heart Failure in Patients with Preserved and Mildly Reduced Ejection Fraction and Type 2 Diabetes Mellitus.
Published In:
Medicina (Kaunas, Lithuania), 60(11) (2024)
Database ID:
RPEP-08426

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-08426·https://rethinkpeptides.com/research/RPEP-08426

APA

Ianos, Raluca Diana; Iancu, Mihaela; Pop, Calin; Lucaciu, Roxana Liana; Hangan, Adriana Corina; Rahaian, Rodica; Cozma, Angela; Negrean, Vasile; Mercea, Delia; Procopciuc, Lucia Maria. (2024). Predictive Value of NT-proBNP, FGF21, Galectin-3 and Copeptin in Advanced Heart Failure in Patients with Preserved and Mildly Reduced Ejection Fraction and Type 2 Diabetes Mellitus.. Medicina (Kaunas, Lithuania), 60(11). https://doi.org/10.3390/medicina60111841

MLA

Ianos, Raluca Diana, et al. "Predictive Value of NT-proBNP, FGF21, Galectin-3 and Copeptin in Advanced Heart Failure in Patients with Preserved and Mildly Reduced Ejection Fraction and Type 2 Diabetes Mellitus.." Medicina (Kaunas, 2024. https://doi.org/10.3390/medicina60111841

RethinkPeptides

RethinkPeptides Research Database. "Predictive Value of NT-proBNP, FGF21, Galectin-3 and Copepti..." RPEP-08426. Retrieved from https://rethinkpeptides.com/research/ianos-2024-predictive-value-of-ntprobnp

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.